Central Venous Catheter Occlusion: A Prospective, Controlled Trial Examining the Impact of a Positive-Pressure Valve Device

Journal of Parenteral and Enteral Nutrition

Volumn 28, Issue 2, 2004, Pages 113-118

  Jacobs, Brian R ^a,b   Schilling, Susan ^a   Doellman, Darcy ^a   Hutchinson, Nancy ^a   Rickey, Melissa ^a   Nelson, Shannen ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Divisions of Adolescent Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CATHETER INFECTION; CATHETER OCCLUSION; CENTRAL VENOUS CATHETER; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; INTENSIVE CARE UNIT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OCCLUSION; PATIENT SATISFACTION; PEDIATRIC SURGERY; PHLEBITIS; POSITIVE PRESSURE VALVE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; VALVE;

EID: 1642317008     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607104028002113     Document Type: Article

References (23)

1. Stephens LC, Haire WD, Kotulak GD. Are clinical signs accurate indicators of the cause of central venous catheter occlusion? JPEN. 1995;19:75-79.
2. Borow M, Crowley JG. Prevention of thrombosis of central venous catheters. J Cardiovasc Surg. 1986;27:571-574.
3. Hinson EK, Blough LD. Skilled iv therapy clinicians' product evaluation of open-ended versus closed-ended valve PICC lines: a cost savings clinical report. J Intraven Nurs. 1996;19;198-210.
4. Hoffer EK, Borsa J, Santulli P, Bloch R, Fontaine AB. Prospective randomized comparison of valved versus nonvalved peripherally inserted central vein catheters. Am J Roentgenol. 1999;173:1393-1398.
5. Thiagarajan RR, Ramamoorthy C, Gettmann T, Bratton SL. Survey of the use of peripherally inserted central venous catheters in children. Pediatrics. 1997;99:E4.
6. Rumsey KA, Richardson DK. Management of infection and occlusion associated with vascular access devices. Semin Oncol Nurs. 1995;11:174-183.
7. Krafte-Jacobs B, Sivit CJ, Mejia R, Pollack MM. Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Pediatr. 1995;126:50-54.
8. Talbott GA, Winters WD, Bratton SL, O'Rourke PP. A prospective study of femoral catheter-related thrombosis in children. Arch Pediatr Adolesc Med. 1995;149:288-291.
9. Jacobs BR, Haygood M, Hingl J. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr. 2001;139:593-596.
10. Chathas MK, Paton JB. Sepsis outcomes in infants and children with central venous catheters: percutaneous versus surgical insertion. J Obstet Gynecol Neonatal Nurs. 1996;25:500-506.
11. Brismar B, Hardstedt C, Jacobson S. Diagnosis of thrombosis by catheter phlebography after prolonged central venous catheterization. Ann Surg. 1981;194:779-783.
12. Cassidy FP Jr, Zajko AB, Bron KM, Reilly JJ Jr, Peitzman AB, Steed DL. Noninfectious complications of long-term central venous catheters: radiologic evaluation and management. Am J Roentgenol. 1987;149:671-675.
13. Suojanen JN, Brophy DP, Nasser I. Thrombus on indwelling central venous catheters: the histopathology of "Fibrin sheaths." Cardiovasc Intervent Radiol. 2000;23:194-197.
14. Tschirhart JM, Rao MK. Mechanism and management of persistent withdrawal occlusion. Am Surg. 1988;54:326-328.
15. Timoney JP, Malkin MG, Leone DM, et al. Safe and cost effective use of alteplase for the clearance of occluded central venous access devices. J Clin Oncol. 2002;20:1918-1922.
16. Wachs T. Urokinase administration in pediatric patients with occluded central venous catheters. J Intraven Nurs. 1990;13:100-102.
17. Lokich JJ, Both A, Benotti P. Complications and management of implanted central venous catheters. J Clin Oncol. 1985;3:710-717.
18. Abdul-Rauf A, Gauderer M, Chiarucci K, Berman B. Long-term central venous access in patients with sickle cell disease: incidence of thrombotic and infectious complications. J Pediatr Hematol Oncol. 1995;17:342-345.
19. Stephens LC, Haire WD, Tarantolo S, et al. Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells (PBSC). Transfus Sci. 1997;18:187-193.
20. Haire WD, Edney JA, Landmark JD, Kessinger A. Thrombotic complications of subclavian apheresis catheters in cancer patients: prevention with heparin infusion. J Clin Apheresis. 1990;5:188-191.
21. Shah P, Shah V. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database Syst Rev. 2001;3:CD002772.
22. Bagnall-Reed H, Jones GR, Dillon P, et al. Urokinase for prevention of central venous catheter occlusions and infections: results of the Children's Cancer Group study CCG-S921. J Pediatr Oncol Nurs. 2002;19:48-49.
23. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest. 1998;113:165-171.